InvestorsHub Logo
Followers 14
Posts 3242
Boards Moderated 1
Alias Born 08/19/2015

Re: skitahoe post# 459921

Sunday, 05/26/2024 8:30:19 PM

Sunday, May 26, 2024 8:30:19 PM

Post# of 462416
At least that company was honest enough to tell people that the trial failed, but Misleading is stringing along investors with his endless delay tactics and buzzwords. No company needs 1.5 years to provide complete trial data; he is just using the peer review process as a cover to delay. The guy lied about Rett last December so that he could get his full bonus. He is not here to increase shareholder value; he is here to make himself rich. Made up endpoints and biomarkers not going to work with FDA, he knows that hence no NDA filing.

Even BIVI admitted that their trial failed, and ANVS provided subgroup data in timely manner. However, AVXL never provides any meaningful data. Instead, he spends so much time trying to find a needle in a haystack by using different statistical methods to suit his narrative. For Rett, he was forced to admit failure; otherwise, he would have used AUC to obscure the results.

We are still waiting for PDD full data and peer review paper, catalyst list is another story with this company, that list never changes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News